| 000 | 00845nam a2200277 i 4500 | ||
|---|---|---|---|
| 999 |
_c127545 _d127545 _x1 |
||
| 001 | 127545 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102114257.0 | ||
| 007 | ta | ||
| 008 | 191230t2020 xxka || 001 0 eng d | ||
| 020 | _a9780198749318 | ||
| 040 |
_aDLC _bspa _cDLC _dES-MaUEC |
||
| 050 | 4 |
_aRS420 _b.R67 2020 |
|
| 100 | 1 |
_aRostron, Chris _eautor _996219 |
|
| 245 | 1 | 0 |
_aDrug design and development _cChris Rostron |
| 264 | 1 |
_aOxford (United Kingdom) _bOxford University Press _c[2020] |
|
| 264 | 4 | _a2020 | |
| 300 |
_a352 páginas _bilustraciones _c25 cm |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _asin mediación _bn |
||
| 338 |
_2rdacarrier _avolumen _bnc |
||
| 650 | 7 |
_2embne _9395061 _aMedicamentos _xDiseño |
|
| 650 | 7 |
_2embne _9137892 _aMedicamentos _xInvestigación |
|
| 942 |
_2lcc _cM1S |
||
| 998 |
_b11/2020 _da _ea _zSI |
||